{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:47:11Z","timestamp":1790261231133,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.vaccine.2012.09.049","type":"journal-article","created":{"date-parts":[[2012,9,29]],"date-time":"2012-09-29T17:46:19Z","timestamp":1348940779000},"page":"7271-7277","source":"Crossref","is-referenced-by-count":38,"title":["Immune interference in the setting of same-day administration of two similar inactivated alphavirus vaccines: Eastern equine and western equine encephalitis"],"prefix":"10.1016","volume":"30","author":[{"given":"Ronald B.","family":"Reisler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul H.","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise K.","family":"Danner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen F.","family":"Boudreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.09.049_bib0005","series-title":"Clinical virology","first-page":"1241","article-title":"Alphaviruses","author":"Smith","year":"2009"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0010","series-title":"Fields virology","first-page":"1023","article-title":"Alphaviruses","author":"Griffin","year":"2007"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0015","series-title":"Vaccines for biodefense and emerging and neglected diseases","first-page":"340","article-title":"Alphaviral encephalitides","author":"Weaver","year":"2009"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0020","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4269\/ajtmh.2007.76.285","article-title":"Human eastern equine encephalitis in Massachusetts: predictive indicators from mosquitoes collected at 10 long-term trap sites, 1979-2004","volume":"76","author":"Hachiya","year":"2007","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2012.09.049_bib0025","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4049\/jimmunol.63.3.313","article-title":"Immunization of laboratory workers with purified Venezuelan equine encephalomyelitis vaccine","volume":"63","author":"Randall","year":"1949","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0030","series-title":"Vaccines","first-page":"1123","article-title":"Biodefense and special pathogen vaccines","author":"Pittman","year":"2008"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1128\/IAI.4.1.37-43.1971","article-title":"Cross-protection in hamsters immunized with group A arbovirus vaccines","volume":"4","author":"Cole","year":"1971","journal-title":"Infec Immun"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0040","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1128\/AEM.26.4.485-488.1973","article-title":"Possible evidence for interference with Venezuelan equine encephalitis virus vaccination of equines by pre-existing antibody to eastern or western equine encephalitis virus, or both","volume":"26","author":"Calisher","year":"1973","journal-title":"Appl Microbiol"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0045","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1016\/j.vaccine.2009.02.090","article-title":"Immune interference after sequential alphavirus vaccine vaccinations","volume":"27","author":"Pittman","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0050","unstructured":"Centers for disease control and prevention. General recommendations on immunization: recommendations of the advisory committee on immunization practices (ACIP). MMWR 2011; 60(RR02):1\u201360."},{"key":"10.1016\/j.vaccine.2012.09.049_bib0055","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4269\/ajtmh.1970.19.119","article-title":"An inactivated eastern equine encephalomyelitis vaccine propagated in chick-embryo cell culture. I. Production and testing","volume":"190","author":"Maire","year":"1970","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0060","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4269\/ajtmh.1971.20.146","article-title":"Inactivated western equine encephalomyelitis vaccine propagated in chick embryo cell culture: clinical and serological evaluation in man","volume":"20","author":"Bartelloni","year":"1971","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0065","series-title":"Medical aspects of biological warfare","first-page":"465","article-title":"Medical countermeasures","author":"Rusnak","year":"2007"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0070","doi-asserted-by":"crossref","first-page":"593","DOI":"10.4269\/ajtmh.1988.39.593","article-title":"Isolation of a newly recognized Bunyawera serogroup virus from a febrile human in Panama","volume":"39","author":"Mangiafico","year":"1988","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0075","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1016\/j.vaccine.2005.12.055","article-title":"Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine","volume":"24","author":"Hepburn","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0080","unstructured":"SAS Institute Incorporated. Cary, NC;, 2009."},{"key":"10.1016\/j.vaccine.2012.09.049_bib0085","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/514240","article-title":"Immunologic interference from sequential administration of live attenuated Alphavirus vaccines","volume":"177","author":"McClain","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0090","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1073\/pnas.81.15.4702","article-title":"An evolutionary tree relating eight alphaviruses, based on amino terminal sequences of their glycoproteins","volume":"81","author":"Bell","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.vaccine.2012.09.049_bib0095","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jviromet.2009.11.006","article-title":"A multisystem approach for development and evaluation of inactivated vaccines for Venezuelan equine encephalitis virus (VEEV)","volume":"163","author":"Fine","year":"2010","journal-title":"J Virol Methods"},{"issue":"15","key":"10.1016\/j.vaccine.2012.09.049_bib0100","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1016\/j.vaccine.2011.01.087","article-title":"Local innate and adaptive immune responses regulate inflammatory cell influx into the lungs after vaccination with formalin inactivated RSV","volume":"29","author":"Kruijsen","year":"2011","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.vaccine.2012.09.049_bib0105","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1016\/j.vaccine.2009.02.062","article-title":"Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus","volume":"27","author":"Tiwari","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2012.09.049_bib0110","doi-asserted-by":"crossref","first-page":"e30898","DOI":"10.1371\/journal.pone.0030898","article-title":"Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity","volume":"7","author":"Budimir","year":"2012","journal-title":"PLoS One"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2012.09.049_bib0115","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.vetimm.2008.08.007","article-title":"Investigation of antigen specific lymphocyte responses in healthy horses vaccinated with an inactivated West Nile virus vaccine","volume":"126","author":"Davis","year":"2008","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0120","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1016\/j.vaccine.2010.01.065","article-title":"Co-administration of viral vector-based vaccines suppresses antigen-specific effector CD8T cells","volume":"28","author":"Yashima","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0125","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1016\/j.vaccine.2009.05.017","article-title":"Harnessing the unique local immunostim ulatory properties of modified vaccinia Ankara (MVA) virus to generate superior tumor-specific immune responses and antitumor activity in a diver-sified prime and boost vaccine regimen","volume":"27","author":"Hodge","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0130","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0264-410X(95)00168-Z","article-title":"Long-term duration of detectable neutralizing antibodies after administration of live attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine","volume":"14","author":"Pittman","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0135","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1016\/j.vaccine.2011.02.037","article-title":"Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study","volume":"29","author":"Rusnak","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0140","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1016\/j.vaccine.2008.04.054","article-title":"Sexual dimorphism of humoral immunity with human vaccines","volume":"26","author":"Cook","year":"2008","journal-title":"Vaccine"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2012.09.049_bib0145","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1016\/j.vaccine.2009.01.086","article-title":"Gender effects on humoral immune responses to smallpox vaccine","volume":"27","author":"Kennedy","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0150","doi-asserted-by":"crossref","unstructured":"Sex differences in the vaccine-specific and non-targeted effects of vaccines\u2014conference report. Vaccine 2011; 29:2349\u20132354.","DOI":"10.1016\/j.vaccine.2011.01.071"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0155","doi-asserted-by":"crossref","first-page":"6159","DOI":"10.1016\/j.vaccine.2010.07.026","article-title":"Immune response of single dose vaccination against 2009 pandemic influenza A (H1N1) in the Taiwanese elderly","volume":"28","author":"Kao","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0160","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2334-7-120","article-title":"Evaluation of immune response to hepatitis B vaccine in health care workers at a tertiary care hospital in Pakistan: an observational prospective study","volume":"7","author":"Zeeshan","year":"2007","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0165","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/ije\/23.5.1078","article-title":"Sex differences in the humoral antibody response to live measles vaccine in young adults","volume":"23","author":"Green","year":"1994","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0170","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1001\/archinternmed.2008.513","article-title":"Half- vs full-dose trivalent inactivated influenza vaccine (2004\u20132005): age, dose, and sex effects on immune responses","volume":"168","author":"Engler","year":"2008","journal-title":"Arch Int Med"},{"issue":"3","key":"10.1016\/j.vaccine.2012.09.049_bib0175","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1590\/S1413-86702009000300013","article-title":"Reference range for T lymphocytes populations in blood donors from two different regions in Brazil","volume":"13","author":"Torres","year":"2009","journal-title":"Brazil J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2012.09.049_bib0180","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2249.2007.03573.x","article-title":"Factors associated with CD4 lymphocyte counts in HIV-negative Senegalese individuals","volume":"151","author":"Mair","year":"2008","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2012.09.049_bib0185","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10522-008-9138-6","article-title":"The immune risk profile is associated with age and gender: findings from three Swedish population studies of individuals 20-100 years of age","volume":"9","author":"Wikby","year":"2008","journal-title":"Biogerontology"},{"issue":"5","key":"10.1016\/j.vaccine.2012.09.049_bib0190","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/gene.2009.12","article-title":"Stronger inflammatory\/cytotoxic T-cell response in women identified by microarray analysis","volume":"10","author":"Hewagama","year":"2009","journal-title":"Genes Immun"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2012.09.049_bib0195","doi-asserted-by":"crossref","first-page":"J282","DOI":"10.1016\/j.jaut.2011.11.013","article-title":"Sex affects immunity","volume":"38","author":"Pennell","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0200","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1465-9921-11-103","article-title":"Asthma and gender impact accumulation of T cell subtypes","volume":"11","author":"Loza","year":"2010","journal-title":"Respir Res"},{"issue":"8","key":"10.1016\/j.vaccine.2012.09.049_bib0205","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1586\/erv.11.73","article-title":"Protective efficacy of live attenuated influenza vaccine (multivalent, Ann Arbor strain): a literature review addressing interference","volume":"10","author":"Bandell","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0210","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.vaccine.2009.01.005","article-title":"The influence of carrier protein on the immunogenicity of simultaneously administered conjugate vaccines in infants","volume":"27","author":"Pollabauer","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0215","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1016\/j.vaccine.2010.06.026","article-title":"Glycoconjugate vaccines and immune interference: a review","volume":"28","author":"Dagan","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0220","unstructured":"Prevnar 13 [package insert]. Philadelphia, PA: Wyeth Pharmaceuticals Corp; Dec 2011."},{"issue":"11","key":"10.1016\/j.vaccine.2012.09.049_bib0225","doi-asserted-by":"crossref","first-page":"894","DOI":"10.4161\/hv.6.11.12852","article-title":"Concomitant administration of zoster and pneumococcal vaccines in adults \u226560 years old","volume":"6","author":"MacIntyre","year":"2010","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0230","doi-asserted-by":"crossref","first-page":"6327","DOI":"10.1016\/j.vaccine.2011.05.019","article-title":"Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella","volume":"29","author":"Silva","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0235","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1016\/j.vaccine.2009.12.080","article-title":"Immunogenicity of an inactivated Japanese encephalitis vaccine (JE-VAX) in humans over 20 years at USAMRIID: using PRNT50 as an endpoint for immunogenicity","volume":"28","author":"Reisler","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.09.049_bib0240","doi-asserted-by":"crossref","first-page":"825","DOI":"10.4269\/ajtmh.2009.08-0625","article-title":"Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: how alterations in assay conditions impact performance","volume":"81","author":"Thomas","year":"2009","journal-title":"Am J Trop Med Hyg"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12013692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12013692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:11:17Z","timestamp":1687738277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12013692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":48,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0264410X12013692"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.09.049","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}